原发性肝癌的临床治疗进展研究  

Clinical treatment of primary liver cancer

作　　者：徐建明[1] 

机构地区：[1]四川省崇州市人民医院普外科,四川崇州611230

出　　处：《医药前沿》2016年第1期8-10,共3页Journal of Frontiers of Medicine

摘　　要：原发性肝癌（PHC）是临床常见的一种恶性肿瘤，起病隐匿，且病情进展迅速，临床治疗难度大，患者生存期短。该病多伴有慢性肝炎、肝硬化及肥胖等疾病，一般确诊时已经发展为晚期或者已经发生转移，治疗效果并不理想。目前临床治疗PHC多以手术为主，非手术治疗效果也十分显著，例如放化疗、生物治疗等。祖国医学博大精深，在治疗原发性肝癌上也有十分显著的效果，引起临床医生关注。本文对原发性肝癌临床治疗方法进行如下综述。Primary liver cancer （PHC） is one of clinical common malignant tumor, onset hidden, and progress rapidly, clinical treatment is difficult, survival period is short. The disease is often accompanied by chronic hepatitis, cirrhosis, and diseases such as obesity. It has been developed for late when confirmed, or transfers have occurred, the treatment effect is not ideal. At present, the clinical treatment of PHC is given priority to with surgery, non-surgical treatment effect is significant. And profound traditional Chinese medicine, in the treatment of primary liver cancer also has a significant effect, has aroused the attention of clinicians. In this paper, the clinical treatment of primary liver cancer were reviewed.

关 键 词：原发性肝癌 手术治疗 放化疗 分子靶向治疗 中药药治疗 

分 类 号：R256.4[医药卫生—中医内科学]